MétaCan
Menu
Retour à la cohorte
Enregistrement W2326712837 · doi:10.1002/oby.21458

Carnosine: Potential aid for diabetes and cardiovascular disease

2016· letter· en· W2326712837 sur OpenAlexaff
Carlo Lombardi, Marco Metra

Notice bibliographique

RevueObesity · 2016
Typeletter
Langueen
DomaineMedicine
ThématiqueBiochemical effects in animals
Établissements canadiensSurgical Specialties (Canada)
Organismes subventionnairesnon disponible
Mots-clésCarnosineMedicineDiabetes mellitusHyperinsulinemiaType 2 diabetesInsulin resistanceInternal medicineEndocrinologyNephropathyDisease

Résumé

récupéré en direct d'OpenAlex

In 2015 more than 250 scientific papers published in international journals analyzed the potential beneficial effects of oral administration of carnosine in a wide range of diseases. There is strong evidence that demonstrates the ability of carnosine to improve cellular metabolism and muscle performance. Carnosine is a powerful antioxidant, acts as a buffer system of pH slowing muscular acidosis, and increases the release of nitric oxide enhancing endothelial function (1). The interest around this dipetide (β-alanyl-l-histidine) present in large amounts in skeletal muscle is derived from the demonstration that in humans the oral administration of carnosine increases exercise tolerance and functional capacity in both healthy subjects and recently in patients with heart failure and depression (2, 3). Animal studies have suggested that oral supplementation of carnosine can prevent diabetes and non-cardiovascular complications associated with this disease such as diabetes-induced nephropathy and ocular diseases (4, 5). There is a strong relationship between cardiovascular disease and diabetes (5). The identification of novel treatments for diabetes and the control of risk factors for obesity, metabolic syndrome, and sedentary lifestyle are still the objectives of the research. The article by de Courten et al. (6) in this issue examines for the first time the effect of oral administration of carnosine in overweight subjects randomized to receive 2 mg per day of carnosine or placebo for 3 months. The results show carnosine's ability to hamper insulin resistance and associated fasting hyperinsulinemia. In addition, carnosine supplementation normalized 2-h glucose and decreased 2-h insulin levels in individuals with impaired glucose tolerance. Although this study was methodologically well conducted, there are some important limitations: 1) the number of patients is limited and the cardiovascular risk profile was rather low because there were no patients with hypertension and lipid profile was normal; 2) the authors used indirect methods to calculate the plasma levels of insulin and its release; 3) it is unclear whether any changes in the diet were able to alter the impact of carnosine in the final results. Despite these observations, this preliminary data confirm the results of many studies that attribute carnosine's ability to prevent the formation of advanced lipoxidation end-products (ALEs) and advanced glycoxidation end-products (AGEs) (1). These molecules are associated with cell aging and are directly involved in the processes that induce hyperglycemia and subsequently diabetes; they have also been associated with the early onset of microvascular complications typical of diabetes. The mechanisms by which AGEs alter cell activity by stimulating atherosclerosis and diabetes include: glycation of intracellular proteins, activation through specific receptor (RAGE) that increases the secretion of endothelin-1, vascular endothelial growth factor (VEGF), and numerous cytokines. Hipkiss et al. have widely documented the ability of carnosine to inhibit the formation of AGEs and ALEs (7). Carnosine has also showed the ability to regulate the autonomic nervous system by preserving or increasing β-cells within the pancreas. This mechanism is responsible for the increase in pancreatic insulin secretion and the subsequent reduction of release of glucagon. The study by de Courten et al. (6) suggests the use of carnosine proved free of side effects as a potential treatment for the reduction of hyperglycemia and hyperinsulinemia in individuals at risk of developing diabetes. The authors are to be commended for their study which adds another piece to the puzzle of the complex relationships among carnosine and metabolism. These data in sedentary individuals with overweight and obesity still require replication in other large studies before carnosine supplementation can become part of the standard medical approach for the metabolic syndrome.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,066
Score d'incertitude au seuil0,906

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,009
Tête enseignante GPT0,225
Écart entre enseignants0,216 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations5
Publié2016
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueObesityMême sujetBiochemical effects in animalsTravaux en français237 207